ProQR Therapeutics N.V. — Company profile
Healthcare · Biotechnology · Netherlands
Last price 1.44 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 203.21M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. The company also develops AX-2402, which targets methyl CpG binding protein 2 mutations for Rett syndrome; AX-2911, which targets PNPLA3 for metabolic dysfunction-associated steatohepatitis; and AX-1412, which targets the B4GALT1 gene for cardiovascular diseases. It has a research and collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
Details
| Name | ProQR Therapeutics N.V. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 186.6 |
| Founded | 2012 |
| Ipo Date | 2014-09-18 |
| Ceo | Daniel de Boer |
| Country | Netherlands |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| Isin | NL0010872495 |
| Cusip | N71542109 |
| Cik | 0001612940 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Daniel Anton de Boer | Founder, Chief Executive Officer and Executive Director |
| Dr. Gerard Platenburg Ph.D. | Co-Founder, Chief Scientific Officer and Executive Director |
| Dennis Hom | Chief Financial Officer |
| Sheila Sponselee | Chief People and Operations Officer |
| Sarah Cue Kiely | Vice President of Investor Relations and Corporate Communications |
| Dr. Cristina Lopez Lopez M.D., Ph.D. | Chief Medical Officer |
| Christopher Hart Ph.D. | Chief Data and AI Officer |
| Dr. Golnar Karimian | Head of Hepatology |
| Sandra van der Kolk | Junior Financial Controller |
Contact
| Address | Zernikedreef 9, Leiden, 2333 CK, Netherlands |
| Phone | 31 88 166 7000 |
| Website | https://www.proqr.com |